AC Immune SA
ACIU •
Buy Open
Signal type
Buy
Status
Open
Open Price
$3.49
Stop Loss
$3.07
Performance
-8.60%
Days Open
6
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 9, 2026
Open Price $3.49
Stop Loss $3.07
Timespan Day
Company Profile
Name AC Immune SA
Ticker ACIU
Market Cap $204.22M
Sector
Latest Close $3.19
List Date Sep 23, 2016
Description
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Website Open Company Website